Inhibition of human placental 17beta-HSD2 assessed as formation of [2,4,6,7-3H]-estrone using [2,4,6,7-3H]-estradiol as substrate after 20 mins by radio flow detector-based HPLC analysis in presence of NAD+ as cofactor
Inhibition of human placental 17beta-HSD1 using [2,4,6,7-3H]-estrone as substrate after 10 mins by radio flow detector-based HPLC analysis in presence of NADH as cofactor
Displacement of [3H]estradiol from human recombinant ERalpha assessed as relative binding affinity after 1 hr by liquid scintillation counting relative to estradiol
Displacement of [3H]estradiol from human recombinant ERbeta assessed as relative binding affinity after 1 hr by liquid scintillation counting relative to estradiol
Inhibition of 17beta-HSD2 in common marmoset placental microsomal fraction assessed as inhibition of [3H]E2 conversion to E1 at 1 uM by scintillation counting analysis
Inhibition of 17beta-HSD2 in mouse liver microsomal fraction assessed as inhibition of [3H]E2 conversion to E1 at 1 uM by scintillation counting analysis
Inhibition of 17beta-HSD2 in rat liver microsomal fraction assessed as inhibition of [3H]E2 conversion to E1 at 1 uM by scintillation counting analysis
Inhibition of human recombinant 11beta-HSD2 expressed in HEK293 cell using [1,2,6,7-3H]cortisol as substrate at 2 uM after 10 mins by scintillation counting analysis
Inhibition of human recombinant 11beta-HSD1 expressed in HEK293 cell using [1,2-3H]Cortisone as substrate after 10 mins by scintillation counting analysis
Inhibition of human recombinant 11beta-HSD1 expressed in HEK293 cell using [1,2-3H]Cortisone as substrate at 2 uM after 10 mins by scintillation counting analysis
Inhibition of human recombinant 17beta-HSD5 expressed in Escherichia coli using [1,2,6,7-3H]A-dione as substrate at 1 uM by scintillation counting analysis
Inhibition of human recombinant 17beta-HSD4 SDR domain expressed in Escherichia coli using [6,7-3H]E2 as substrate at 1 uM by scintillation counting analysis